A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study Evaluating the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)

  • Sandhu, Manjeet (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date5/07/24 → 4/07/29

Clinical Trial Phase

  • Phase II